Repurposing artesunate in acute myeloid leukemia: a pharmacokinetic rationale derived from antimalarial data
Cancer Chemotherapy and Pharmacology · 29.04.2026 · 96 (1)
DOI: 10.1007/s00280-026-04881-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 29.04.2026. Verfasst von Woei Jye Ong. Beteiligte Einrichtung: Cytotoxic Drug Reconstitution Unit, Pharmacy Department, Miri General Hospital, Sarawak, Malaysia. ongwoeijye@moh.gov.my. Hauptthemen laut MEDLINE: Artesunate, Antimalarials, Leukemia, Myeloid, Acute, Drug Repositioning. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cytotoxic Drug Reconstitution Unit, Pharmacy Department, Miri General Hospital, Sarawak, Malaysia. ongwoeijye@moh.gov.my.
Zitieren
APA
Ong, W. J. (2026). Repurposing artesunate in acute myeloid leukemia: a pharmacokinetic rationale derived from antimalarial data. Cancer Chemotherapy and Pharmacology, 96(1). https://doi.org/10.1007/s00280-026-04881-1
Vancouver
Ong WJ. Repurposing artesunate in acute myeloid leukemia: a pharmacokinetic rationale derived from antimalarial data. Cancer Chemotherapy and Pharmacology. 2026;96(1). doi:10.1007/s00280-026-04881-1
BibTeX
@article{Ong2026,
author = {Ong, Woei Jye},
title = {Repurposing artesunate in acute myeloid leukemia: a pharmacokinetic rationale derived from antimalarial data},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2026},
volume = {96},
number = {1},
doi = {10.1007/s00280-026-04881-1}
}
EUVIMED